Related Experiment Video
Updated: Aug 12, 2026
09:55
From Constructs to Crystals – Towards Structure Determination of β-barrel Outer Membrane Proteins
Published on: July 4, 2016
Anti-infective compounds for Yersinia
Kumar D Gahlot1, Matthew S Francis1, Jyoti M Gurung1
1Department of Molecular Biology, and Umeå Centre for Microbial Research, Umeå University, SE-90187 Umeå, Sweden.
Sustainable Microbiology
|August 11, 2026
Summary
This review examines antibacterial compounds against Yersinia infections, covering traditional antibiotics and new strategies like targeting virulence factors and host interactions for better treatment outcomes.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Yersinia bacteria cause significant human and animal diseases.
- Effective treatment strategies for Yersinia infections are crucial for public health.
Purpose of the Study:
- To review current and emerging antibacterial compounds for Yersinia infections.
- To evaluate novel therapeutic strategies beyond traditional antibiotics.
- To identify challenges and opportunities in managing Yersinia infections.
Main Methods:
- Literature review of traditional antibiotic therapies.
- Analysis of novel strategies targeting virulence factors.
- Exploration of host-pathogen interactions and vaccine development.
Main Results:
- Traditional antibiotics remain a cornerstone of Yersinia treatment.
- Novel approaches show promise in overcoming resistance and enhancing efficacy.
- Vaccine development presents a potential long-term prevention strategy.
Conclusions:
- A multifaceted approach combining traditional and novel therapies is essential.
- Further research into virulence factors and host-pathogen dynamics is needed.
- Improved clinical outcomes depend on addressing current challenges and embracing new opportunities.
Keywords:
Yersinia infectionsnovel anti-bacterial strategiestraditional antibiotic therapiesvaccine developmentvirulence factorsMore Related Videos
Related Concept Videos
01:24Plague
Plague is a highly virulent zoonotic disease caused by Yersinia pestis, a Gram-negative, facultatively anaerobic coccobacillus. This pathogen primarily circulates among rodent populations and is transmitted to humans through the bite of infected fleas. Additional transmission routes include direct contact with infected animal tissue or inhalation of respiratory droplets from individuals with pneumonic plague. These multiple transmission pathways highlight the bacterium’s potential for rapid...
01:26Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:25Antibody Structure and Classes
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
00:42Cross-reactivity
Overview
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...